Human medicines European public assessment report (EPAR): Natpar, parathyroid hormone, Date of authorisation: 24/04/2017, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR): Dimethyl fumarate Polpharma, dimethyl fumarate, Date of authorisation: 13/05/2022, Revision: 5, Status: Withdrawn

Vaxzevria: Periodic safety update report assessment 29 June 2022 to 28 December 2022

Human medicines European public assessment report (EPAR): Ivabradine Anpharm, ivabradine, Date of authorisation: 08/09/2015, Revision: 10, Status: Authorised

Spikevax : Periodic safety update report assessment 19 June 2022 to 17 December 2022

Human medicines European public assessment report (EPAR): Procoralan, ivabradine, Date of authorisation: 25/10/2005, Revision: 22, Status: Authorised

EudraVigilance training and support

Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the EU: hands-on training course using the EudraVigilance system, Online, from 3 June 2024 to 7 June 2024

Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the EU: hands-on training course using the EudraVigilance system, Online, from 13 May 2024 to 17 May 2024

Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the EU: hands-on training course using the EudraVigilance system, Online, from 15 April 2024 to 19 April 2024